YSG

Yatsen Holding Ltd. (YSG) | Rumor.io

Yatsen Holding

YSG

Attention (50-day avg)0%

Attention rank (50-day avg)#2,847

Bullish sentiment (50-day avg)100%

Price to earnings ratio-3.2

Market capitalization237.3M

Earnings per share-0.33

Dividend yield (TTM)—

Revenue (annual)4.3B

Net income (annual)-92.4M

Social

What share of all stock conversation is about YSG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Nov 17

Yatsen Holding Limited's ($YSG) third quarter 2025 financial results showed a 47.5% increase in total net revenues to RMB 998.4 million.
The company's skincare brands experienced an 83.2% year-over-year increase in net revenues, reaching 49.2% of total revenue.
Yatsen's gross profit for 2025 increased by 51.9% to RMB 780.5 million, with a gross margin of 78.2%.

Generated by AI

Sentiment

Of the messages about YSG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100%	94.74% +2.28
Bearish	—	—	0%	5.26% -2.28

Bullish· Jul 14

$YSG is a strong momentum play, with a 25.4% intraday gain and a 151.9M float.
Analysts are mildly confident in $YSG, with a 78% buy consensus and a potential breakout above $2.20.
$YSG has a high short float of 6.4%, indicating potential for a short squeeze and further price appreciation.

Bearish· Jul 6

$YSG has been identified as a top watch, with a thesis confirmed by volume candle and offers.
The asset's recent price action has been characterized as a dump, with some traders noting a significant price drop and others referencing a bearish engulfing pattern.
The CEO's Harvard education and potential involvement in a hedge fund may be a factor in the asset's short-term performance, with some traders speculating about the timing of a potential buyback.

Generated by AI

Topics

Of the messages about YSG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	33.33%	60%	56.36%
Macro	—	33.33%	16%	18.18%
Earnings	—	0%	16%	14.55%
Controversies	—	33.33%	8%	3.64%
Analysts	—	0%	0%	7.27%
Technical Analysis	—	0%	0%	0%

Oct 31

Mainz Biomed's ColoAlert is gearing up for FDA trials in 2025, potentially paving the way for US market access.
Mainz Biomed has upgraded ColoAlert, which could be a game-changer in cancer diagnostics.
Mainz Biomed's partnerships in Europe and beyond are expanding its global reach, with the US market possibly next.

Generated by AI

Community

Of the messages about YSG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	33.33%	8.99%	29.39%
Newcomers	—	66.67%	91.01%	70.61%

Regulars· Mar 18

Regulars discuss Yatsen Holding Limited's American Depositary Shares, which each represent four Class A shares, in the context of trending stocks on March 18, 2024.
The focus is on YSG's status as a trending stock, rather than its underlying company performance.
No specific market analysis or insights are provided regarding Yatsen Holding Limited's business or financials in this post.

Newcomers· Nov 6

New users are highlighting Mainz Biomed's FDA plans for ColoAlert, a key milestone in 2025.
Growth and technology are driving early cancer detection, a trend being discussed among newcomers.
The focus is on the early cancer detection market, with $YSG mentioned as part of a broader discussion.

Generated by AI

The company is using technology for things like new ingredient discovery as Chinese consumers seek increasingly individualized products image credit: Bamboo Works Key Takeaways: Yatsen is turning to AI and

8d agoBenzinga

How Perfect Diary owner Yatsen plans to give its business a glow-up

The Chinese beauty firm has snapped up a string of overseas skincare brands, but it now plans to focus on expanding its existing portfolio.

11d agoSouth China Morning Post

Yatsen (YSG) Reported 40.4% Skincare Growth but a Larger GAAP Operating Loss. Can Portfolio Mix Outrun Marketing Intensity?

Yatsen Holding Limited (NYSE:YSG) reported second-quarter 2026 total net revenues of RMB1.14 billion, up 5.1% year over year, as skincare net revenues increased 40.4%. Skincare represented 71.5% of total net revenues, confirming rapid progress in the portfolio shift. However, color-cosmetics net revenues declined 35.8%, while the GAAP operating loss widened to RMB131.9 million from RMB55.5 […]

21d agoYahoo Finance

Yatsen Group Releases 2025 ESG Report: The Vision of a World-Class Beauty Innovation Pioneer Through Long-Term Value

26d agoMorningstar

Yatsen Q2 Earnings Call Highlights

Yatsen (NYSE:YSG) reported second-quarter 2026 revenue growth of 5.1% as continued strength in its skincare portfolio offset a sharp decline in color cosmetics sales, while higher inventory provisions and increased marketing spending widened the company’s losses. Total net revenue rose to RMB1.14 b

27d agoYahoo Finance

Yatsen Q2 2026 slides: skincare surge drives revenue mix shift

27d agoInvesting.com

Also Discussed

Investors talking about YSG also mention

#	Name	Attention
1	17 Education & Technology Group Inc. American Depositary SharesYQ	0%0
2	DADA - Dada Nexus Limited	——
3	Zhihu Inc. - ADRZH	0%new
4	Vroom Inc.VRM	0%0
5	KE Holdings Inc. ADRBEKE	0%new
6	FRGE - Forge Global Holdings, Inc.	——
7	PLYA - Playa Hotels & Resorts N.V.	——
8	PGRE - Paramount Group, Inc.	——
9	Pebblebrook Hotel TrustPEB	0%new
10	Atea Pharmaceuticals, Inc.AVIR	0%0

Yatsen Holding Ltd.

Consumer Defensive
Household & Personal Products

Yatsen Holding Ltd. is an innovative beauty and skincare company originating from China. The primary function of Yatsen is to develop, market, and sell a diverse range of beauty products, which span across categories such as skincare, make-up, and personal care. The company is particularly known for its popular brands including Perfect Diary, Little Ondine, and Abby's Choice, which appeal to a broad consumer base through both online platforms and offline retail channels. Yatsen Holding Ltd. leverages advanced technologies in data analytics and consumer insights to tailor its product offerings, ensuring it meets the dynamic preferences of customers. Operating primarily within the Asian beauty market, Yatsen has made significant inroads into expanding its global footprint. The company's significance in the market is underscored by its ability to swiftly adapt and launch innovative products that capture the interests of a new generation of beauty consumers, making it a key player in the competitive beauty industry.

Website

Location

Poly Development Plaza

Guangzhou, 510335

China

Social

What share of all stock conversation is about YSG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Nov 17

Yatsen Holding Limited's ($YSG) third quarter 2025 financial results showed a 47.5% increase in total net revenues to RMB 998.4 million.
The company's skincare brands experienced an 83.2% year-over-year increase in net revenues, reaching 49.2% of total revenue.
Yatsen's gross profit for 2025 increased by 51.9% to RMB 780.5 million, with a gross margin of 78.2%.

Generated by AI

Sentiment

Of the messages about YSG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100%	94.74% +2.28
Bearish	—	—	0%	5.26% -2.28

Bullish· Jul 14

$YSG is a strong momentum play, with a 25.4% intraday gain and a 151.9M float.
Analysts are mildly confident in $YSG, with a 78% buy consensus and a potential breakout above $2.20.
$YSG has a high short float of 6.4%, indicating potential for a short squeeze and further price appreciation.

Bearish· Jul 6

$YSG has been identified as a top watch, with a thesis confirmed by volume candle and offers.
The asset's recent price action has been characterized as a dump, with some traders noting a significant price drop and others referencing a bearish engulfing pattern.
The CEO's Harvard education and potential involvement in a hedge fund may be a factor in the asset's short-term performance, with some traders speculating about the timing of a potential buyback.

Generated by AI

Topics

Of the messages about YSG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	33.33%	60%	56.36%
Macro	—	33.33%	16%	18.18%
Earnings	—	0%	16%	14.55%
Controversies	—	33.33%	8%	3.64%
Analysts	—	0%	0%	7.27%
Technical Analysis	—	0%	0%	0%

Oct 31

Mainz Biomed's ColoAlert is gearing up for FDA trials in 2025, potentially paving the way for US market access.
Mainz Biomed has upgraded ColoAlert, which could be a game-changer in cancer diagnostics.
Mainz Biomed's partnerships in Europe and beyond are expanding its global reach, with the US market possibly next.

Generated by AI

Community

Of the messages about YSG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	33.33%	8.99%	29.39%
Newcomers	—	66.67%	91.01%	70.61%

Regulars· Mar 18

Regulars discuss Yatsen Holding Limited's American Depositary Shares, which each represent four Class A shares, in the context of trending stocks on March 18, 2024.
The focus is on YSG's status as a trending stock, rather than its underlying company performance.
No specific market analysis or insights are provided regarding Yatsen Holding Limited's business or financials in this post.

Newcomers· Nov 6

New users are highlighting Mainz Biomed's FDA plans for ColoAlert, a key milestone in 2025.
Growth and technology are driving early cancer detection, a trend being discussed among newcomers.
The focus is on the early cancer detection market, with $YSG mentioned as part of a broader discussion.

Generated by AI

Yatsen Holding

Social

Nov 17

Sentiment

Bullish· Jul 14

Bearish· Jul 6

Topics

Oct 31

Community

Regulars· Mar 18

Newcomers· Nov 6

News

Yatsen Turns To AI For Beauty In The Eye Of The Beholder - Yatsen Holding (NYSE:YSG)

How Perfect Diary owner Yatsen plans to give its business a glow-up

Yatsen (YSG) Reported 40.4% Skincare Growth but a Larger GAAP Operating Loss. Can Portfolio Mix Outrun Marketing Intensity?

Yatsen Group Releases 2025 ESG Report: The Vision of a World-Class Beauty Innovation Pioneer Through Long-Term Value

Yatsen Q2 Earnings Call Highlights

Yatsen Q2 2026 slides: skincare surge drives revenue mix shift

Also Discussed

Yatsen Holding Ltd.

Company Information

Location

News

Yatsen Turns To AI For Beauty In The Eye Of The Beholder - Yatsen Holding (NYSE:YSG)

How Perfect Diary owner Yatsen plans to give its business a glow-up

Yatsen (YSG) Reported 40.4% Skincare Growth but a Larger GAAP Operating Loss. Can Portfolio Mix Outrun Marketing Intensity?

Yatsen Group Releases 2025 ESG Report: The Vision of a World-Class Beauty Innovation Pioneer Through Long-Term Value

Yatsen Q2 Earnings Call Highlights

Yatsen Q2 2026 slides: skincare surge drives revenue mix shift

Also Discussed

Social

Nov 17

Sentiment

Bullish· Jul 14

Bearish· Jul 6

Topics

Oct 31

Community

Regulars· Mar 18

Newcomers· Nov 6